Exelixis
EXEL
#1553
Rank
HK$114.86 B
Marketcap
HK$463.57
Share price
1.03%
Change (1 day)
59.84%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company